BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24316338)

  • 1. PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivo.
    Jin ZH; Furukawa T; Sogawa C; Claron M; Aung W; Tsuji AB; Wakizaka H; Zhang MR; Boturyn D; Dumy P; Fujibayashi Y; Saga T
    Eur J Pharm Biopharm; 2014 Apr; 86(3):478-86. PubMed ID: 24316338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
    Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Degardin M; Sugyo A; Tsuji AB; Yamasaki T; Kawamura K; Fujibayashi Y; Zhang MR; Boturyn D; Dumy P; Saga T
    Mol Cancer Ther; 2016 Sep; 15(9):2076-85. PubMed ID: 27422811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.
    Jin ZH; Furukawa T; Ohya T; Degardin M; Sugyo A; Tsuji AB; Fujibayashi Y; Zhang MR; Higashi T; Boturyn D; Dumy P; Saga T
    Nucl Med Commun; 2017 Apr; 38(4):347-355. PubMed ID: 28291159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
    Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
    Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Claron M; Boturyn D; Coll JL; Fukumura T; Fujibayashi Y; Dumy P; Saga T
    Angiogenesis; 2012 Dec; 15(4):569-80. PubMed ID: 22644563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
    Briat A; Wenk CH; Ahmadi M; Claron M; Boturyn D; Josserand V; Dumy P; Fagret D; Coll JL; Ghezzi C; Sancey L; Vuillez JP
    Cancer Sci; 2012 Jun; 103(6):1105-10. PubMed ID: 22448775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotheranostic Agent
    Jin ZH; Tsuji AB; Degardin M; Sugyo A; Obara S; Wakizaka H; Nagatsu K; Hu K; Zhang MR; Dumy P; Boturyn D; Higashi T
    Clin Cancer Res; 2020 Dec; 26(23):6230-6241. PubMed ID: 32933998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
    van Eerd JE; Vegt E; Wetzels JF; Russel FG; Masereeuw R; Corstens FH; Oyen WJ; Boerman OC
    J Nucl Med; 2006 Mar; 47(3):528-33. PubMed ID: 16513623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.
    Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M
    J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniform intratumoral distribution of radioactivity produced using two different radioagents,
    Jin ZH; Tsuji AB; Degardin M; Sugyo A; Yoshii Y; Nagatsu K; Zhang MR; Fujibayashi Y; Dumy P; Boturyn D; Higashi T
    EJNMMI Res; 2018 Jun; 8(1):54. PubMed ID: 29923139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
    Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
    Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of succinylated gelatine with a (99m)Tc-bombesin analogue, effects on pharmacokinetics and tumor uptake.
    Liolios CC; Xanthopoulos S; Loudos G; Varvarigou AD; Sivolapenko GB
    Nucl Med Biol; 2016 Oct; 43(10):625-34. PubMed ID: 27497631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
    Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
    Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
    Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.